Diabetes mellitus Diabetes mellitus, Diabetic complications
Conditions
Interventions
None listed
Sponsors
Sono Tsuneaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: 1. Individuals aged 18 years or older. 2. Individuals who have a fasting blood glucose level of equql to or larger than 126 mg/dl, a 75 g OGTT 2-hour value of equql to or larger than 200 mg/dl, or a random blood glucose level of equql to or larger than 200 mg/dl in two or more tests. 3. Individuals with normal capacity to consent. 4. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 5. Individuals for whom the attending physician has recognized the necessity of treatment.
Exclusion criteria
Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who have a random blood glucose level of > 300 mg/dL. 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Condition of the patient - Blood sugar level - HbA1c - Renal function - Blood pressure - Severity of diabetes | — |
Countries
Japan, nose
Contacts
Public ContactTsuneaki Sono
Tokyo Showa Clinic
Outcome results
None listed